1 28 May 2020 Subject: Explanation of operating result in the financial statement ended 31 March 2020 To: Directors and Managers of the Stock Exchange of Thailand With reference to the audited
Investors and Private Funds ___________________________ By virtue of Section 16/6 of the Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008
and Private Funds ___________________________ By virtue of Section 16/6 of the Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008
Stock Exchange of Thailand Notice is hereby given that the Board of Directors’ Meeting of Kaset Thai International Sugar Corporation Public Company Limited (the “Company”) No. 1/2020 held on November 25
SN.LK. 005/2019 February 21, 2019 Subject : Management Discussion and Analysis for the year ended 31 December 2018 Attn : The President The Stock Exchange of Thailand Indara Insurance Public Company
No. SN.LK 003/2018 February 20, 2018 The President Stock Exchange of Thailand Dear Sir: Indara Insurance Public Company Limited would like to report the company ‘s operating results and submit the
13 May 2019 Subject: Management Discussion and Analysis for the Quarter 1 Ending 31 March 2019 Attention: President Stock Exchange of Thailand Please find below the additional information supporting
31st March 2018 To : Managing Director Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at
November 8, 2018 SET-18-AC-003 Dear The President The Stock Exchange of Thailand Subject: Clarification of Result’s Operation for the three months ended 30 September 2018 According to the resolution